| Literature DB >> 33731430 |
Furong Zeng1,2,3, Zhizhao Chen1,3,4, Rao Chen1,5, William J Shufesky1, Mohna Bandyopadhyay6, Geoffrey Camirand1,7, Martin H Oberbarnscheidt1,7, Mara L G Sullivan8, Catherine J Baty9, Mu-Qing Yang1, Michel Calderon8, Donna Beer Stolz8, Geza Erdos6, Roberta Pelanda10, Todd V Brennan11, Sergio D Catz12, Simon C Watkins8, Adriana T Larregina6,7,13, Adrian E Morelli14,7.
Abstract
Despite the role of donor-specific antibodies (DSAs) in recognizing major histocompatibility complex (MHC) antigens and mediating transplant rejection, how and where recipient B cells in lymphoid tissues encounter donor MHC antigens remains unclear. Contrary to the dogma, we demonstrated here that migration of donor leukocytes out of skin or heart allografts is not necessary for B or T cell allosensitization in mice. We found that mouse skin and cardiac allografts and human skin grafts release cell-free donor MHC antigens via extracellular vesicles (EVs) that are captured by subcapsular sinus (SCS) macrophages in lymph nodes or analog macrophages in the spleen. Donor EVs were transported across the SCS macrophages, and donor MHC molecules on the EVs were recognized by alloreactive B cells. This triggered B cell activation and DSA production, which were both prevented by SCS macrophage depletion. These results reveal an unexpected role for graft-derived EVs and open venues to interfere with EV biogenesis, trafficking, or function to restrain priming or reactivation of alloreactive B cells.Entities:
Mesh:
Year: 2021 PMID: 33731430 PMCID: PMC8939235 DOI: 10.1126/scitranslmed.abb0122
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956